Catherine Alix-Panabières: The next ISMRC 2025 is just a few weeks away
Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier, reshared a post by International Symposium on Minimal Residual Cancer on LinkedIn, adding:
“Welcome to the next ISMRC 2025… just a few weeks away!
We are delighted to showcase our German-French collaboration, featuring the esteemed Prof. Sonja Loges, Director of the Department of Personalized Oncology and DKFZ German Cancer Research Center – Hector Cancer Institute, Heidelberg—alongside many other distinguished colleagues from Germany.
Check out the amazing program and register here.
Looking forward to seeing you there!
Quoting International Symposium on Minimal Residual Cancer‘s post:
“Prof. Sonja Loges will explore how liquid biopsy is shaping the future of immunotherapy response prediction and monitoring.
As Managing Director of the DKFZ German Cancer Research Center and Chair of Personalized Oncology in Mannheim, she leads cutting-edge research to refine targeted therapies and combat treatment resistance.
Join the discussion at the ISMRC2025 on Liquid Biopsy and Immunotherapy!
The ISMRC2025 is organized by Paul Hofman, Catherine Alix-Panabières & Klaus Pantel.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023